|
Form Serial Number: |
DA20201229E00017
|
1.
Date of relevant event: |
23/12/2020 (dd/mm/yyyy)
|
2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
3.
Stock code: |
06618 |
4.
Name of listed corporation: |
JD Health International Inc. |
5.
Class of shares: |
Ordinary Shares |
6.
Number of issued shares in class: |
3,184,367,111 |
7.
Name of director (English) as printed on HKID Card/Passport: |
(Surname) |
Xin |
(Other names) |
Lijun |
|
|
|
10.
Name of director (Chinese): |
辛利軍 |
11.
Chinese Character Code as printed on HKID Card: |
|
|
24.
Details of relevant event: |
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
Long position |
1213 | The number of shares in which you are interested has reduced because: any other event (you must briefly describe the relevant event in the Supplementary Information box) | |
|
|
|
|
|
|
|
|
Short position |
|
|
|
|
|
|
|
|
|
|
|
25.
Total shares in listed corporation immediately before the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 38,834,967 | 1.24 |
|
|
26.
Total shares in listed corporation immediately after the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 38,834,967 | 1.22 |
|
|
27.
Capacity in which interests disclosed in Box 26 are held: |
Code describing capacity | Number of shares |
| |
2201 | Interest of corporation controlled by you |
| |
|
|
28.
Further information in derivative interests in listed corporation : |
Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
Long position | 4106 | Unlisted derivatives - Cash settled |
| 01/10/2020 | 01/10/2030 | USD | 0 | USD | 0.000 | | | 29,282,729 |
|
|
29.
Further information in relation to interests of children under 18 and/or spouse: |
Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
|
30.
Further information in relation to interests of corporations controlled by Director: |
Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
Novacare Investment Limited | Craigmuir Chambers, Road Town, Tortola, VG 1110, British Virgin Islands | Xin Lijun | 93.09 | Y | |
|
|
31.
Further information in relation to interests held by Director jointly with another person: |
Name of joint shareholder | Address | Number of shares |
| | |
|
|
32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
Names of Trust | Address | Status code | Number of shares |
| | | |
|
|
33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
Names of other parties | Address | Number of shares |
| | |
Total number of shares in which a director is interested under sections 317 and 318 | |
|
|
34.
Supplementary information: |
The percentage level of interest in the shares has decreased due to full exercise of over-allotment option (see announcement dated 21 December 2020 of the Company for more details). In boxes 27 and 30, the long position of 9,552,238 shares is held by Novacare Investments Limited, which is beneficially owned by Xin Lijun as to 93.09% with the remaining interest beneficially owned by 13 other employees of the Group who are not directors or senior management of the Company (see prospectus).
|
35.
Log/Serial Number of the previous form: |
|
36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
Date of filing this Form 3A: |
29/12/2020 (dd/mm/yyyy)
|
|